Safety and Preliminary Efficacy of PalinGen Flow Amniotic Tissue Allograft in Chronic Ulcers of the Lower Extremities
Phase 2
Active, not recruiting
- Conditions
- Chronic Ulcer of Lower Extremity
- Interventions
- Biological: PalinGen Flow Amniotic Tissue Allograft
- First Posted Date
- 2020-12-14
- Last Posted Date
- 2024-03-20
- Lead Sponsor
- Amnio Technology, LLC
- Target Recruit Count
- 82
- Registration Number
- NCT04667416
- Locations
- 🇺🇸
Acclaim Bone & Joint Institute and Plastic Surgery, Fort Worth, Texas, United States
🇺🇸Limb Preservation Platform, Fresno, California, United States
🇺🇸Center for Clinical Research, San Francisco, California, United States
© Copyright 2025. All Rights Reserved by MedPath